Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: 14 days- Dose finding study; non-GLP

Data source

Reference
Reference Type:
publication
Title:
2,4,5-Trichloranilin - BUA-Bericht Nr 227
Author:
BUA
Year:
2001
Bibliographic source:
S. Hirzel Verlag Stuttgart, Germany 2001

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
Deviations:
yes
Remarks:
Only a 14 day gavage study of orientating character, no clinical chemistry data. Organ weights only from liver, renals, spleen, testes and ovaries. Histological data only from liver and spleen.
GLP compliance:
no
Remarks:
Methods were identical to GLP studies but no inspection was performed
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2,4,5-trichloroaniline
EC Number:
211-254-9
EC Name:
2,4,5-trichloroaniline
Cas Number:
636-30-6
Molecular formula:
C6H4Cl3N
IUPAC Name:
2,4,5-trichloroaniline
Details on test material:
- Name of test material (as cited in report): 2,4,5-Trichloroaniline

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
14 days
Frequency of treatment:
Once daily at seven days a week.
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 60, 250 and 1000mg/kg bw
Basis:
actual ingested
No. of animals per sex per dose:
5
Control animals:
yes, concurrent vehicle
Details on study design:
This study was planned a dose range finder study for a subacute toxicity study.

Examinations

Observations and examinations performed and frequency:
no data
Sacrifice and pathology:
GROSS PATHOLOGY: Yes
Organ weight: Liver
HISTOPATHOLOGY: Yes, spleen and liver only

Results and discussion

Results of examinations

Clinical signs:
not specified
Mortality:
not specified
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
reduced gain
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
effects observed, treatment-related
Description (incidence and severity):
increase
Ophthalmological findings:
not specified
Haematological findings:
not specified
Clinical biochemistry findings:
not specified
Urinalysis findings:
not specified
Behaviour (functional findings):
not specified
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Description (incidence and severity):
Liver
Gross pathological findings:
effects observed, treatment-related
Histopathological findings: non-neoplastic:
effects observed, treatment-related
Description (incidence and severity):
liver, spleen
Histopathological findings: neoplastic:
not specified

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion